Q2 2025 · 13F-HR
Sio Capital Management, LLCholdings as filed
Filed 2025-08-13 · accession 0001214659-25-011950
$261.8M
Reported value
52
Positions
2025-06-30
Period end
The Brief · Sio Capital Management, LLC · Q2 2025
AI · grounded in 13F
Sio Capital Management, LLC established a new position in MMS valued at $38.48M. The fund also initiated new stakes in IRON for $15.08M and GMED for $14.49M. Additional new positions include CNC at $14.25M, MRK at $13.77M, and DRUG at $13.38M. The fund ended the period with 52 positions and total AUM of $261.84M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 577933104 | MMS | MAXIMUS INC | $38.5M | 14.7% | 548,086 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $15.1M | 5.76% | 284,787 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $14.5M | 5.54% | 245,570 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $14.2M | 5.44% | 262,500 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $13.8M | 5.26% | 173,951 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $13.4M | 5.11% | 512,338 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $12.7M | 4.84% | 100,725 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $12.4M | 4.73% | 225,114 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $9.8M | 3.75% | 4,095,764 | Common | SOLE |
| 45168D104 | IDXX | IDEXX LABS INC | $9.7M | 3.69% | 18,000 | PUT | SOLE |
| 80105N105 | SNY | SANOFI | $9.1M | 3.46% | 187,500 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $7.8M | 2.96% | 810,274 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $7.4M | 2.81% | 112,923 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $7.1M | 2.70% | 539,730 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $7.0M | 2.66% | 1,839,022 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $6.2M | 2.36% | 584,435 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $4.9M | 1.89% | 158,736 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $4.4M | 1.68% | 236,070 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $4.2M | 1.62% | 2,075,139 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $4.0M | 1.51% | 3,735,396 | Common | SOLE |
| 05350V106 | AVNS | AVANOS MED INC | $3.5M | 1.35% | 288,849 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $3.3M | 1.26% | 62,719 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $3.1M | 1.20% | 947,489 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $3.0M | 1.15% | 1,299,300 | PUT | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $2.8M | 1.07% | 1,307,964 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $2.7M | 1.05% | 241,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2.6M | 1.00% | 124,230 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $2.4M | 0.93% | 335,937 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $2.4M | 0.92% | 478,343 | Common | SOLE |
| 64130M209 | — | NEUROONE MED TECHNOLOGIES CO | $2.4M | 0.91% | 3,523,663 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $2.3M | 0.88% | 4,852,298 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $1.8M | 0.69% | 122,210 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $1.7M | 0.66% | 1,369,748 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.7M | 0.65% | 318,256 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $1.7M | 0.63% | 726,851 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $1.4M | 0.52% | 178,774 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $1.2M | 0.47% | 636,300 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.2M | 0.45% | 845,531 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $879,040 | 0.34% | 1,341,636 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $736,337 | 0.28% | 2,232,000 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $585,439 | 0.22% | 785,824 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $577,578 | 0.22% | 122,889 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $472,134 | 0.18% | 279,369 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $380,276 | 0.15% | 50,839 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $360,143 | 0.14% | 72,173 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $302,028 | 0.12% | 31,169 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $165,316 | 0.06% | 163,679 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $60,398 | 0.02% | 131,300 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $37,673 | 0.01% | 10,100 | Common | SOLE |
| 44486Q111 | HUMAW | HUMACYTE INC | $18,749 | 0.01% | 49,998 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $13,620 | 0.01% | 400,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $5,577 | 0.00% | 1,100 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.